Literature DB >> 12599076

Survival of Streptococcus pyogenes within host phagocytic cells: a pathogenic mechanism for persistence and systemic invasion.

Eva Medina1, Oliver Goldmann, Antonia W Toppel, Gursharan S Chhatwal.   

Abstract

Streptococcus pyogenes is generally an extracellular pathogen that can survive and persist within the host by circumventing the host defense mechanisms. To achieve this, S. pyogenes has developed a number of strategies to circumvent the host immune system (e.g., virulence factors directed to prevent phagocytosis). By use of a murine model of skin infection, it was shown that survival within host phagocytic cells constitutes an additional strategy used by S. pyogenes to evade the host defenses and disseminate. Viable microorganisms were isolated from mouse phagocytic cells after in vitro or during in vivo infection. The capacity of intracellularly located bacteria to establish infection was demonstrated by the efficiency of gentamicin-treated neutrophils isolated from infected mice to transfer infection when injected intravenously into naive mice. The ability of S. pyogenes to exploit the inflammatory response of the host by surviving inside phagocytic cells may constitute an additional virulence mechanism of this pathogen.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12599076     DOI: 10.1086/373998

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  32 in total

1.  SpyA, a C3-like ADP-ribosyltransferase, contributes to virulence in a mouse subcutaneous model of Streptococcus pyogenes infection.

Authors:  Jessica S Hoff; Mark DeWald; Steve L Moseley; Carleen M Collins; Jovanka M Voyich
Journal:  Infect Immun       Date:  2011-03-21       Impact factor: 3.441

2.  Keratinocyte production of cathelicidin provides direct activity against bacterial skin pathogens.

Authors:  Marissa H Braff; Mohamed Zaiou; Joshua Fierer; Victor Nizet; Richard L Gallo
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

Review 3.  Toward a genome-wide systems biology analysis of host-pathogen interactions in group A Streptococcus.

Authors:  James M Musser; Frank R DeLeo
Journal:  Am J Pathol       Date:  2005-12       Impact factor: 4.307

Review 4.  Tissue tropisms in group A streptococcal infections.

Authors:  Debra E Bessen; Sergio Lizano
Journal:  Future Microbiol       Date:  2010-04       Impact factor: 3.165

5.  The FasX Small Regulatory RNA Negatively Regulates the Expression of Two Fibronectin-Binding Proteins in Group A Streptococcus.

Authors:  Jessica L Danger; Nishanth Makthal; Muthiah Kumaraswami; Paul Sumby
Journal:  J Bacteriol       Date:  2015-09-21       Impact factor: 3.490

6.  SalY of the Streptococcus pyogenes lantibiotic locus is required for full virulence and intracellular survival in macrophages.

Authors:  Hilary A Phelps; Melody N Neely
Journal:  Infect Immun       Date:  2007-06-18       Impact factor: 3.441

7.  Characterization of the invasive and inflammatory traits of oral Campylobacter rectus in a murine model of fetoplacental growth restriction and in trophoblast cultures.

Authors:  R M Arce; P I Diaz; S P Barros; P Galloway; Y Bobetsis; D Threadgill; S Offenbacher
Journal:  J Reprod Immunol       Date:  2010-01-20       Impact factor: 4.054

8.  Effect of salivary agglutination on oral streptococcal clearance by human polymorphonuclear neutrophil granulocytes.

Authors:  A Itzek; Z Chen; J Merritt; J Kreth
Journal:  Mol Oral Microbiol       Date:  2016-07-10       Impact factor: 3.563

9.  Intracellular survival of Streptococcus pyogenes in polymorphonuclear cells results in increased bacterial virulence.

Authors:  Eva Medina; Manfred Rohde; Gursharan S Chhatwal
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

10.  M1 protein triggers a phosphoinositide cascade for group A Streptococcus invasion of epithelial cells.

Authors:  Sai Sudha Purushothaman; Beinan Wang; P Patrick Cleary
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.